Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound, is suing four telehealth companies for allegedly selling illegal copies of the drug made by compounding pharmacies.

  • themeatbridge@lemmy.world
    link
    fedilink
    arrow-up
    29
    ·
    3 days ago

    … Zepbound sticker price of more than $1,086.37 a month. For comparison, compounded tirzepatide sells for as little as $99 a month.

    • GrundlButter@lemmy.dbzer0.com
      link
      fedilink
      arrow-up
      13
      ·
      2 days ago

      I believe the Canadian cost for the name brand drug is around $300-400/month, and some articles indicate a cost of $319/mo in Japan. Apparently the costs for a similar drug, ozempic, are even more of a stark contrast, at around $1000/mo domestically, and $100/mo internationally.

      This is a black market created entirely due to the greed of Eli Lily and Novo Nordisk. That if this class of drugs were priced fairly in the United States, the black market would not have had a chance to take root. Pricing them fairly would reduce the reliance on sketchy compounding pharmacies, and would improve the safety of American patients. Failure to do so at this point is actively harming people out of pure greed, which is nothing new.

      I can’t help but cheer for compounding pharmacies for fighting these greedy goliaths, and I hope their actions harm Eli Lily and Novo Nordisk as much as possible. I hope it ushers in an era of pirate medicine that erodes drug maker profits permanently.

      • 50MYT@lemmy.world
        link
        fedilink
        arrow-up
        2
        ·
        2 days ago

        Yes.

        But.

        Look at the clown in Australia that’s spamming half the global market with the compounding version he makes in his shit lab. The vials come to the customer by post, with a melted ice pack. They are blood red…

        And half the people who took it went to hospital.